Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride with PEG or Lactulose in Women with Chronic Constipation
NCT02228616Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2014
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of prucalopride in chronic constipation, sponsored by Janssen Pharmaceutical. Primary endpoint: Percentage of subjects with a weekly average increase of 1 or more Spontaneous Complete Bowel Movement (SCBM) at 12 weeks. Started Oct 2014; status: completed.
02
Drugs
prucalopride
03
Conditions
chronic constipation
Beyond the preview
Go deeper on NCT02228616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02228616.